Bryan Dechairo is the President, CEO, and Director at Sherlock Biosciences. Sherlock Biosciences is an innovative biotech company that is enabling the democratization and decentralization of diagnostic testing to personalize healthcare and make an impact on global health.
The Sherlock team and founders include engineering biology pioneers with world-leading expertise in CRISPR and synthetic biology, diagnostic industry veterans, and disease area authorities. Together, they provide an unparalleled set of capabilities that are transforming molecular diagnostics in clinical and non-clinical settings.
Before Sherlock, and most recently, Bryan was Executive VP at Myriad Genetics and CSO and CMO at Assurex Health. His extensive career spans over two decades and also includes prominent positions at Medco Health, Pfizer, Oxagen Sequana Therapeutics, and Roche. Bryan's experience working at both startups and Fortune 500 companies gives him unique insights that any entrepreneur can benefit from.
Get the latest insights from The Biotech Startups Podcast delivered straight to your inbox.
Subscribe to our twice-weekly newsletter for updates, news, and more—everything you need to stay ahead in biotech.